Celexa (Citalopram)

Medication Information & Treatment Considerations

Celexa (citalopram) is a prescription medication that may be considered by a licensed psychiatric provider as part of a treatment plan when clinically appropriate. Treatment recommendations are based on an individual’s symptoms, medical history, treatment goals, and overall clinical evaluation. Celexa works by affecting serotonin activity in the brain, a neurotransmitter involved in mood regulation and emotional processing. Individual experiences with medication vary, and treatment outcomes depend on many factors unique to each person. Celexa is not a controlled substance and must be prescribed by a licensed psychiatric provider. Through Telemynd, medication may be prescribed following a secure virtual evaluation when clinically appropriate. Many insurance plans cover Celexa, and generic options are widely available. Some people may experience side effects such as nausea, dry mouth, fatigue, sleep changes, dizziness, or sweating, particularly when starting treatment. Your provider will monitor your response to treatment and make adjustments as needed.

Important Safety Information

Celexa may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults. Individuals beginning treatment should be monitored for worsening symptoms, unusual changes in behavior, or suicidal thoughts. Celexa may affect heart rhythm in some individuals and may not be appropriate for everyone. Before starting or changing any medication, discuss potential risks, benefits, side effects, warnings, and drug interactions with your healthcare provider. For complete prescribing information, please review the current FDA-approved prescribing information for Celexa (citalopram).

Educational Notice

This content is provided for informational and educational purposes only and should not be considered medical advice, treatment recommendations, or a guarantee that any medication will be prescribed. Medication decisions are made by licensed healthcare providers following a comprehensive clinical evaluation and consideration of individual needs.

Last reviewed: June 2026. Prescribing information may change. Refer to the current FDA-approved labeling for the most up-to-date safety information.